Grow your business safely with VENTURE PHARMA

All the information you need about VENTURE PHARMA to develop and secure your business in France

V HOME > CORPORATES > VENTURE PHARMA > BALANCE SHEET ( 2018-07-20)

THE LIST OF BALANCE SHEET : VENTURE PHARMA

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2021-05-20 Partially confidential 2020-12-31 Complete
2018-07-20 Public 2017-12-31 Complete
2017-07-03 Public 2016-12-31 Complete
NameVENTURE PHARMA
Siren500616180
Closing2017-12-31
Registry code 9201
Registration number 24433
Management number2007B06768
Activity code 7022Z
Closing date n-12016-12-31
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2018-07-20
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address92300 LEVALLOIS PERRET
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AF Concessions, Patents and Similar Rights 18 983.00 18 983.00 18 983.00
AT Other tangible assets 164 557.00 127 581.00 36 976.00 164 557.00
BH Other financial assets 14 900.00 14 900.00 14 900.00
BJ TOTAL (I) 271 819.00 146 563.00 125 256.00 271 819.00
BX Customers and related accounts 587 350.00 587 350.00 587 350.00
BZ Other receivables 49 884.00 49 884.00 49 884.00
CD Marketable securities 21 300.00 56.00 21 244.00 21 300.00
CF Cash and cash equivalents 15 581.00 15 581.00 15 581.00
CH Prepaid expenses 3 814.00 3 814.00 3 814.00
CJ TOTAL (II) 677 930.00 56.00 677 874.00 677 930.00
CO Grand total (0 to V) 949 749.00 146 619.00 803 130.00 949 749.00
CU Other investments 73 380.00 73 380.00 73 380.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 50 000.00 50 000.00 50 000.00
DD Legal reserve (1) 5 000.00 5 000.00 5 000.00
DH Retained earnings 328 834.00 325 986.00 328 834.00
DI RESULTS FOR THE YEAR (Profit or Loss) 29 767.00 2 849.00 29 767.00
DL TOTAL (I) 413 601.00 383 834.00 413 601.00
DV Miscellaneous Loans and Financial Debts (4) 12 734.00 16 842.00 12 734.00
DX Trade payables and related accounts 272 822.00 234 535.00 272 822.00
EA Other liabilities 103 972.00 74 946.00 103 972.00
EC TOTAL (IV) 389 529.00 326 324.00 389 529.00
EE Grand total (I to V) 803 130.00 710 158.00 803 130.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FG Production sold - services 696 960.00 696 960.00 696 960.00
FJ Net sales 696 960.00 696 960.00 696 960.00
FP Reversals of depreciation and provisions, transfer of expenses 19 752.00
FQ Other income 1.00
FR Total operating income (I) 716 713.00
FU Purchases of raw materials and other supplies 38.00
FW Other purchases and external expenses 632 027.00
FX Taxes, duties, and similar payments 9 194.00
FY Salaries and Wages 19 752.00
GA Operating Expenses - Depreciation and Amortization 18 118.00
GE Other Expenses
GF Total Operating Expenses (II) 679 129.00
GG - OPERATING RESULT (I - II) 37 584.00
GQ Financial allocations to depreciation and provisions 56.00
GR Interest and similar expenses 386.00
GT Net expenses on sales of marketable securities 3.00
GU Total financial expenses (VI) 445.00
GV - FINANCIAL INCOME (V - VI) -445.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) 37 139.00
4 - Income statement (continued)Amount year NAmount year N-1
HA Exceptional income from management transactions 400.00 400.00
HD Total exceptional income (VII) 400.00 400.00
HE Exceptional expenses on management operations 753.00 1 711.00 753.00
HH Total exceptional expenses (VIII) 753.00 1 711.00 753.00
HI - EXCEPTIONAL RESULT (VII - VIII) -353.00 -1 711.00 -353.00
HK Income tax 7 019.00 -369.00 7 019.00
HL TOTAL REVENUE (I + III + V + VII) 717 113.00 630 091.00 717 113.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 687 346.00 627 243.00 687 346.00
HN PROFIT OR LOSS (Total revenue - Total expenses) 29 767.00 2 849.00 29 767.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 265 696.00 6 123.00 265 696.00
I3 DECREASES Total Financial Fixed Assets 88 280.00
I4 DECREASES Grand Total 271 819.00
IO DECREASES Total including other intangible assets 18 983.00
IY DECREASES Total Tangible Fixed Assets 164 557.00
KD ACQUISITIONS Total including other intangible assets 18 983.00 18 983.00
LN ACQUISITIONS Total Tangible Fixed Assets 158 434.00 6 123.00 158 434.00
LQ ACQUISITIONS Total Financial Fixed Assets 88 280.00 88 280.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 128 446.00 18 118.00 128 446.00
PE DEPRECIATION Total including other intangible assets 18 983.00 18 983.00
QU DEPRECIATION Total Tangible Fixed Assets 109 463.00 18 118.00 109 463.00
7 - Provisions Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
6X Other provisions for depreciation 56.00
7B Total provisions for depreciation 56.00
7C Grand total 56.00
UG - Financial 56.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8B Suppliers and Related Accounts 272 822.00 272 822.00 272 822.00
8E Income Taxes 4 871.00 4 871.00 4 871.00
UT Other financial assets 14 900.00 14 900.00
UX Other trade receivables 587 350.00 587 350.00
VB VAT 48 878.00 48 878.00
VI Group and Associates 12 734.00 12 734.00 12 734.00
VQ Other Taxes, Duties, and Similar Debts 261.00 261.00 261.00
VR Miscellaneous debtors (including receivables related to repo transactions) 1 006.00 1 006.00
VS Prepaid expenses 3 814.00 3 814.00
VT TOTAL – STATEMENT OF RECEIVABLES 655 949.00 641 049.00 14 900.00 655 949.00
VW VAT 98 840.00 98 840.00 98 840.00
VY TOTAL – STATEMENT OF LIABILITIES 389 529.00 389 529.00 389 529.00
11 - Earnings appropriation & miscellaneous informationAmount for year NAmount for year N-1Amount 1 to 5 yearsAmount more than 5 years
YP Average staff number 7.00 7.00

all companies in France

Complete and comprehensive database.